Kissei Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 9.32% vs 27.88% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -10.25% vs 10.01% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24,773.00",
          "val2": "22,661.00",
          "chgp": "9.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,950.00",
          "val2": "2,696.00",
          "chgp": "-27.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "8.00",
          "val2": "6.00",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "117.00",
          "val2": "-231.00",
          "chgp": "150.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,801.00",
          "val2": "3,121.00",
          "chgp": "-10.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.50%",
          "val2": "67.80%",
          "chgp": "-3.73%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 10.28% vs 16.87% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 16.58% vs 6.08% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "97,406.00",
          "val2": "88,330.00",
          "chgp": "10.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,718.00",
          "val2": "10,570.00",
          "chgp": "-83.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "28.00",
          "val2": "21.00",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "676.00",
          "val2": "-3,203.00",
          "chgp": "121.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13,960.00",
          "val2": "11,975.00",
          "chgp": "16.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-30.00%",
          "val2": "65.40%",
          "chgp": "-9.54%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

24,773.00

22,661.00

9.32%

Operating Profit (PBDIT) excl Other Income

1,950.00

2,696.00

-27.67%

Interest

8.00

6.00

33.33%

Exceptional Items

117.00

-231.00

150.65%

Consolidate Net Profit

2,801.00

3,121.00

-10.25%

Operating Profit Margin (Excl OI)

30.50%

67.80%

-3.73%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 9.32% vs 27.88% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -10.25% vs 10.01% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

97,406.00

88,330.00

10.28%

Operating Profit (PBDIT) excl Other Income

1,718.00

10,570.00

-83.75%

Interest

28.00

21.00

33.33%

Exceptional Items

676.00

-3,203.00

121.11%

Consolidate Net Profit

13,960.00

11,975.00

16.58%

Operating Profit Margin (Excl OI)

-30.00%

65.40%

-9.54%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 10.28% vs 16.87% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 16.58% vs 6.08% in Mar 2025

All Annual Results